✦ LIBER ✦

LDL S-homocysteinylation decrease in chronic kidney disease patients undergone lipid lowering therapy

✍ Scribed by Angelo Zinellu; Salvatore Sotgia; Elisabetta Pisanu; Giacomina Loriga; Luca Deiana; Andrea Ercole Satta; Ciriaco Carru

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Current developments in lipid-lowering t

✍ Burnhope, Emma; Green, Darren; Kalra, Philip A; Kalra, Paul R 📂 Article 📅 2011 🏛 Future Medicine 🌐 English ⚖ 641 KB

LIPID-LOWERING THERAPY IN CHRONIC KIDNEY

✍ Darren Green; Rosica Panayotova; James P. Ritchie; Edmond O’Riordan; John McDona 📂 Article 📅 2012 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 487 KB

Metformin therapy in patients with chron

✍ J. K. Duong; D. M. Roberts; T. J. Furlong; S. S. Kumar; J. R. Greenfield; C. M. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 520 KB

The effect of long-term aggressive lipid

✍ Robert Fathi; Nicole Isbel; Leanne Short; Brian Haluska; David Johnson; Thomas H 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 71 KB

INTENSIVE LIPID LOWERING WITH ATORVASTAT

✍ Shepherd, J.; Wenger, N.K.; Carmena, R.; Deedwania, P. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 137 KB

212: Intensive Lipid Lowering With Atorv

✍ James Shepherd; Nanette K. Wenger; Daniel J. Wilson 📂 Article 📅 2007 🏛 Elsevier 🌐 English ⚖ 130 KB